TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer
| EMCCX Fund | USD 55.97 0.38 0.68% |
Slightly above 52% of Empiric 2500's investor base is interested to short. The analysis of overall sentiment of trading Empiric 2500 Fund mutual fund suggests that many investors are impartial at this time. Empiric 2500's investing sentiment can be driven by a variety of factors including economic data, Empiric 2500's earnings reports, geopolitical events, and overall market trends.
Empiric |
Seagen Inc. today announced data from the Phase 3 HER2CLIMB-02 clinical trial of TUKYSA in combination with the antibody-d
Read at businesswire.com
 |
Empiric 2500 Fundamental Analysis
We analyze Empiric 2500's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Empiric 2500 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Empiric 2500 based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Empiric 2500 is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Empiric 2500 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Empiric 2500 mutual fund to make a market-neutral strategy. Peer analysis of Empiric 2500 could also be used in its relative valuation, which is a method of valuing Empiric 2500 by comparing valuation metrics with similar companies.
Peers
Empiric 2500 Related Equities
| FIKHX | Fidelity Advisor | 0.68 |
| ||
| ITYYX | Invesco Technology | 0.82 |
| ||
| VITAX | Vanguard Information | 0.83 |
| ||
| PGKCX | Pgim Jennison | 1.47 |
| ||
| USTCX | Science Technology | 2.90 |
|
Other Information on Investing in Empiric Mutual Fund
Empiric 2500 financial ratios help investors to determine whether Empiric Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Empiric with respect to the benefits of owning Empiric 2500 security.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Transaction History View history of all your transactions and understand their impact on performance |